宋佳男, 于海波, 刘玉梅. 神经病理性疼痛的治疗和药物发现现状J. 药学学报, 2021,56(3): 679-688. doi: 10.16438/j.0513-4870.2020-1131
引用本文: 宋佳男, 于海波, 刘玉梅. 神经病理性疼痛的治疗和药物发现现状J. 药学学报, 2021,56(3): 679-688. doi: 10.16438/j.0513-4870.2020-1131
SONG Jia-nan, YU Hai-bo, LIU Yu-mei. Current status of treatment and drug discovery for neuropathic painJ. Acta Pharmaceutica Sinica, 2021,56(3): 679-688. doi: 10.16438/j.0513-4870.2020-1131
Citation: SONG Jia-nan, YU Hai-bo, LIU Yu-mei. Current status of treatment and drug discovery for neuropathic painJ. Acta Pharmaceutica Sinica, 2021,56(3): 679-688. doi: 10.16438/j.0513-4870.2020-1131

神经病理性疼痛的治疗和药物发现现状

Current status of treatment and drug discovery for neuropathic pain

  • 摘要: 神经病理性疼痛(neuropathic pain,NP)是一直困扰人类的医学难题,严重影响人民生活质量。尽管近年来关于NP的研究取得了很大进展,但是依旧有很多患者对现有的治疗无效。目前药物治疗依旧是缓解疼痛的主要方法,然而药物不良反应阻碍了疗效的发挥,寻找新型药物靶点及减少现有药物的不良反应迫在眉睫。本综述将主要阐述神经病理性疼痛的现状、发病机制、现有治疗神经病理性疼痛药物的有效性和局限性及新药发现现状。

     

    Abstract: Neuropathic pain (NP) is a medical problem that has been bothering human beings and seriously affects people's quality of life. Although great progress has been made in the study of NP in recent years, there are still many patients who are ineffective to the existing treatments. At present, drug therapy is still the main method to relieve pain, however, adverse drug reactions has hindered the curative effects of drugs. It is extremely urgent to find new drug targets and reduce the adverse effects of existing drugs. This review will mainly describe the current situation and pathogenesis of neuropathic pain, effectiveness and limitations of existing drugs for treating neuropathic pain, and the current status of drug discovery.

     

/

返回文章
返回